U.S. Dermatology Fuses with Japanese Manufacturing: Dermatiq and Allen INTERNATIONAL Announce Strategic Partnership

U.S.-based skincare brand Dermatiq Inc. (Headquarters: Miami, Florida; Founder/CEO: Dr. C. Ryan Kirkland) and comprehensive beauty/health manufacturer Allen INTERNATIONAL Co., Ltd. (Headquarters: Yokkaichi, Mie; Chairman: Shigeki Kawamori) held a joint brand launch and strategic partnership ceremony on Thursday, March 5, 2026, at Hilton Tokyo Odaiba. The event featured presentations by development partners and brand strategists, unveiling the 'Dermatiq' joint brand alongside future plans for AI-integrated skincare devices, target-specific product lines, and global brand strategies focused on the U.S. market.

■ Speakers (Brand Development Partners)
Dr. C. Ryan Kirkland (U.S. Dermatologist / Founder of Dermatiq): Built a skincare theory fusing medicine and beauty based on clinical experience, applying treatment-room insights to consumer products.
Shigeki Kawamori (Chairman, Allen INTERNATIONAL): Oversees product development and brand strategy in beauty and health, expanding business globally through salon-exclusive channels.
Ichiko Takagi (Education/Brand Strategy Lead, Allen INTERNATIONAL): Drives talent development and product education in the salon market based on Japanese manufacturing philosophy.
Alain Dijkstra (Business Development/Global Strategy, Nuon Medical Technologies): Expert in beauty tech, driving the development of skincare devices integrated with light therapy and medical-grade standards.
Stephanie Sanborn (U.S. High-End Marketing Expert): Supports market expansion for premium brands, handling strategy and high-net-worth marketing in North America.

■ AI Diagnosis x Device x Capsule Formulation: Dermatiq's Vision for 'Personalized Skincare'
Dermatiq is a next-generation skincare brand being developed based on U.S. clinical dermatology, aiming for a new system that integrates everything from diagnosis to daily care. At its core is the 'Smart Sense System,' a skincare device equipped with diagnostic functions.

Dr. C. Ryan Kirkland stated: 'In my clinical experience, I've seen many patients whose symptoms progressed because they didn't know the proper skincare. I wanted to make skincare based on medical science and clinical evidence actionable in daily life.' This vision sparked the development of Dermatiq.

The system measures skin condition and proposes optimal skincare via a dedicated app. It tracks usage feedback and records changes over time, offering an integrated design from diagnosis to treatment and progress management. The innovative concept allows one device to be set with serum capsules adjusted for age, gender, and skin type, making it accessible to all targets. The disposable capsules are chosen based on AI results, realizing personalized care for millennials, men, and younger demographics. The first-generation model is expected to feature moisture sensors, heating/vibration for absorption, and LED/microcurrent therapy, bringing medical-grade home care to the mass market by combining U.S. science, Japanese formulation, and high-level technology.